BOE Importance: 6/10

Spain creates CERTERA, a state consortium to develop advanced therapy medicines

03 Oct 2026 Effective: 11 Sep 2026 32 views
Who is affected:
Biomedical research centers, hospitals, universities and pharmaceutical and biotechnology industry

Summary

The Carlos III Health Institute leads the creation of CERTERA, a state network with more than 40 entities to promote the development of advanced therapy medicines in Spain.

Detailed analysis PRO

The agreement signed on 11 September 2026 establishes the State Consortium in Network for the Development of Advanced Therapy Medicines (CERTERA), promoted by the Instituto de Salud Carlos III and CIEMAT together with more than 40 institutions including hospitals, research foundations and universities. Its legal basis …

PRO exclusive content

Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.

Desbloquear análisis PRO Ver planes y precios

Full official title

Resolución de 15 de septiembre de 2026, del Instituto de Salud Carlos III, O.A., M.P., por la que se publica el Convenio con varias entidades, para la creación del Consorcio Estatal en Red para el Desarrollo de Medicamentos de Terapia Avanzada.

Related regulations